Dinesh V. Patel
Board Member
Protagonist Therapeutics, Inc (PTGX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dinesh V. Patel
Dinesh V. Patel is recorded as CEO and Board Member at Protagonist Therapeutics, Inc (PTGX). Protagonist Therapeutics, Inc reported in an 8-K filed June 18, 2026 that Dinesh V. Patel was appointed Class I director, effective June 17, 2026. The proxy statement of Protagonist Therapeutics, Inc reports total compensation of $12,871,506 for Dinesh V. Patel in fiscal 2025, including a base salary of $715,500. Disclosed compensation is on record for 8 fiscal years.
“To elect the two Class I director nominees to hold office until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-17–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Protagonist Therapeutics, Inc
Other people whose current roles at this company are on record from its filings.
- Dinesh Patel CEO, Board Member
- Asif Ali CFO
- Daniel N. Swisher, Jr. Board Member
- Dinesh V. Patel, Ph.D. Board Member
- Lewis T. "Rusty" Williams, M.D., Ph.D. Board Member
- Lewis T. “Rusty” Williams Board Member
- Sarah A. O'Dowd Board Member
- Sarah O'Dowd Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $715,500 | $12,871,506 |
| 2024 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $681,410 | $9,473,819 |
| 2023 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $655,200 | $7,067,572 |
| 2022 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $630,000 | $5,993,238 |
| 2021 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $600,000 | $5,544,733 |
| 2020 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $565,000 | $2,225,622 |
| 2019 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $545,000 | $1,948,344 |
| 2018 | Protagonist Therapeutics, Inc (PTGX) | President and Chief Executive Officer | $520,000 | $3,721,511 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.